← Back
$STRO All transactions

SUTRO BIOPHARMA, INC.

M

$ Value

$0

Shares

53,125

Price

$0

Filed

May 5

Insider

Name

Borgman Anne Elizabeth

Title

CHIEF MEDICAL OFFICER

CIK

0001886388

Roles

Officer

Transaction Details

Transaction Date

2025-05-01

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

21,875

Footnotes

Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of restricted stock units; does not represent a sale by the reporting person. | Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement. | The RSU award vests as to 1/4th of the total award annually on the last calendar day of February, beginning on February 29, 2024, subject to continued service through each vesting date. | The reported transactions represent the accelerated vesting of certain of the reporting person's equity awards outstanding under the issuer's 2018 Equity Incentive Plan and 2021 Equity Inducement Plan, in connection with her separation and transition from her position with the issuer, as previously reported by the issuer in its Current Report filed with the Securities and Exchange Commission on Form 8-K on March 13, 2025. | The RSUs vest as to 1/4th of the total award annually beginning on March 1, 2025, subject to continued service through each vesting date.

Filing Info

Accession No.

0001415889-25-011996

Form Type

4

Issuer CIK

0001382101

Borgman Anne Elizabeth's History

Date Ticker Type Value
2025-06-20 NXTC A $0
2025-05-20 CRIS A $45K
2025-05-01 STRO M $0
2025-05-01 STRO M $0
2025-05-01 STRO F $26K
2025-05-01 STRO M $0
2025-05-01 STRO M $0

Other Insiders at STRO (90d)

Insider Bought Sold Last
Chow Gregory K.
CFO
2026-03-02
Chung Jane
Chief Executive Officer
2026-03-04
Gerber Hans-Peter
CHIEF SCIENTIFIC OFFICER
2026-03-02
Pauling David
Chief Admin. Ofcr. & GC
2026-03-04